SGH
AMRX icon

Sivik Global Healthcare’s Amneal Pharmaceuticals AMRX Stock Holding History

Sivik Global Healthcare’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-600,000
Closed -$2.86M – 42
2020
Q2 		$2.86M Buy
+600,000
New +$2.47M 0.95% 42

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sivik Global Healthcare's AMRX Position: Q3 2020 in Review

Sivik Global Healthcare sold out of Amneal Pharmaceuticals (AMRX) in Q3 2020, closing a stake of 600,000 shares — an estimated $2.86M sold.

Sivik Global Healthcare first reported a position in AMRX in Q2 2020 and held it in 1 quarter. The position peaked at $2.86M in Q2 2020. 140 funds tracked by Wall St. Rank hold AMRX as of Q3 2020.

  • Sivik Global Healthcare reported no remaining Amneal Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Sivik Global Healthcare sold 600,000 Amneal Pharmaceuticals shares in Q3 2020, an estimated $2.86M.
  • Sivik Global Healthcare first reported a position in Amneal Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Sivik Global Healthcare's Amneal Pharmaceuticals position peaked at $2.86M in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2020.

Based on Sivik Global Healthcare's 13F filing for Q3 2020, filed 13 Nov 2020.